Biotechnology and Medical Research (TRBC)
(This August 31 story is refiled to add dropped word founding to Ertl’s title in paragraph 13) By Allison Martell and Julie Steenhuysen TORONTO/CHICAGO (Reuters) [more…]
SEOUL (Reuters) - South Korean prosecutors indicted Samsung Group’s Jay Y. Lee on Tuesday on suspicion of accounting fraud and stock price manipulation in connection [more…]
(Reuters) - The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China’s CanSino Biologics (6185.HK) and Russia’s Gamaleya Institute have been studied for [more…]
SEOUL (Reuters) - South Korean prosecutors indicted Samsung Group leader Jay Y. Lee on charges of manipulating stock prices and breach of trust in order [more…]
(Reuters) - Billionaire entrepreneur Elon Musk’s neuroscience startup Neuralink on Friday unveiled a pig named Gertrude that has had a coin-sized computer chip in its [more…]
BEIJING (Reuters) - China’s vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, [more…]
1/WALL STREET WATCHES WASHINGTON U.S. lawmakers negotiating a fresh dose of stimulus have reached an impasse. Trillions of dollars injected by the Federal Reserve and [more…]
(Reuters) - Warren Buffett’s Berkshire Hathaway Inc (BRKa.N) said on Friday it has sold shares of some of the largest U.S. banks, slashing its stakes [more…]
(Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and [more…]
(Reuters) - As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies [more…]
